AKT1 and type 2 diabetes mellitus: A high dose of liraglutide (200 μg/kg) alleviated learning and cognitive impairment in T2DM rats enhanced autophagic signaling and improved cognitive function by activating PI3K/Akt and AMPK pathways to inhibit p-mTOR expression (196).